Ornithine Decarboxylase Inhibitors
"Ornithine Decarboxylase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances and drugs that inhibit or block the activity of ORNITHINE DECARBOXYLASE.
Descriptor ID |
D065108
|
MeSH Number(s) |
D27.505.519.389.705
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ornithine Decarboxylase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Ornithine Decarboxylase Inhibitors".
This graph shows the total number of publications written about "Ornithine Decarboxylase Inhibitors" by people in this website by year, and whether "Ornithine Decarboxylase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2003 | 1 | 1 | 2 |
2004 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ornithine Decarboxylase Inhibitors" by people in Profiles.
-
Improvement of dermatological symptoms in patients with Bachmann-Bupp syndrome using difluoromethylornithine treatment. Pediatr Dermatol. 2023 May-Jun; 40(3):528-531.
-
Irreversible ototoxicity associated with difluoromethylornithine. Cancer Epidemiol Biomarkers Prev. 2004 Jul; 13(7):1250-2.
-
Mechanisms involved in calcitonin gene-related Peptide-induced relaxation in pregnant rat uterine artery. Biol Reprod. 2003 Nov; 69(5):1635-41.
-
Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice. Carcinogenesis. 2003 May; 24(5):945-52.
-
The future of colon cancer prevention. Ann N Y Acad Sci. 2001 Dec; 952:88-108.
-
Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res. 2000 Apr 01; 60(7):1864-70.
-
Role of polyamines in glucocorticoid effects on pancreatic acinar AR42J cell growth and differentiation. Am J Physiol. 1992 Feb; 262(2 Pt 1):G285-90.
-
Chemoprevention in prostate cancer: the role of difluoromethylornithine (DFMO). J Cell Biochem Suppl. 1992; 16H:122-7.
-
Evaluation of continuous-infusion alpha-difluoromethylornithine therapy for colorectal carcinoma. Cancer Chemother Pharmacol. 1990; 26(3):223-6.
-
Effects of butylated hydroxytoluene upon PUVA-tumorigenesis and induction of ornithine decarboxylase activity in the mouse. J Photochem Photobiol B. 1989 Feb; 3(1):91-100.